VOLUME 57   1996   NUMBER 5


184 Venlafaxine in Adults With Attention-Deficit/Hyperactivity Disorder: An Open Clinical Trial. Robert L. Findling, Michael A. Schwartz, Daniel J. Flannery, and Michael J. Manos

190 Staging Methods for the Assessment of Dementia: Perspectives. Jiska Cohen-Mansfield, Barry Reisberg, Jeannete Bonnema, Leonard Berg, Dolly P. Dastoor, Robert I. Pfeffer, and Gene D. Cohen

199 Asystole in Electroconvulsive Therapy: Report of Four Cases. W. Vaughn McCall

204 Pharmacokinetic Interactions and Side Effects Resulting From Concomitant Administration of Lithium and Divalproex Sodium. G. Richard Granneman, Dennis W. Schneck, John H. Cavanaugh, and Galen F. Witt

207 A Review of the Effects of Moderate Alcohol Intake on the Treatment of Anxiety and Mood Disorders. Ricardo Castaneda, Norman Sussman, Laurence Westreich, Robert Levy, and Mary O'Malley

213 A Pharmacoeconomic Model of Divalproex vs. Lithium in the Acute and Prophylactic Treatment of Bipolar I Disorder. Paul E. Keck, Jr., Azmi A. Nabulsi, Jennifer L. Taylor, Curtis J. Henke, Joseph J. Chmiel, Sean P. Stanton, and Jerry A. Bennett


223 Drug-Drug Interactions. Sheldon H. Preskorn

Reply by C. Lindsay DeVane

227 Fluoxetine-Associated Paresthesias and Alopecia in a Woman Who Tolerated Sertraline. Vinod S. Bhatara, Sanjay Gupta, and Jerome W. Freeman

227 Ketoconazole Therapy for Atypical Depression. Robert Sovner and Steven Fogelman